一种肺炎支原体灭活疫苗。 - Suppr

Suppr

超能文献

An inactivated mycoplasma pneumoniae vaccine.

作者信息

Jensen K E, Senterfit L B, Chanock R M, Smith C B, Purcell R H

出版信息

JAMA. 1965 Oct 18;194(3):248-52.

PMID:4953648

Abstract

摘要

相似文献

An inactivated mycoplasma pneumoniae vaccine.一种肺炎支原体灭活疫苗。

JAMA. 1965 Oct 18;194(3):248-52.

THE ETIOLOGICAL ROLE OF MYCOPLASMA PNEUMONIAE IN OTITIS MEDIA IN CHILDREN.肺炎支原体在儿童中耳炎中的病因学作用

Pediatrics. 1965 Apr;35:652-7.

The isolation and identification of Mycoplasma from Macaca mulatta.

Lab Anim Care. 1970 Jun;20(3):467-70.

Lysis and death of Mycoplasma pneumoniae by antibody and complement.抗体和补体导致肺炎支原体的溶解与死亡。

J Immunol. 1971 Apr;106(4):907-16.

[Studies on the chronic murine pneumonia. Pathogenesis of Mycoplasma pulmonis infection in the rat].

Z Versuchstierkd. 1971;13(4):217-23.

On the incidence of mycoplasma contamination in cell cultures.关于细胞培养中支原体污染的发生率

Zentralbl Bakteriol Orig A. 1972 Apr;219(4):550-4.

Isolation of Mycoplasma pneumoniae from human primary atypical pneumonia.从人类原发性非典型肺炎中分离出肺炎支原体。

Acta Microbiol Acad Sci Hung. 1973 Feb;20(2):103-7.

Respiratory virus vaccines. II. Mycoplasma pneumoniae (Eaton agent) vaccines.呼吸道病毒疫苗。II. 肺炎支原体（伊顿氏因子）疫苗。

Am Rev Respir Dis. 1966 Jul;94(1):1-9. doi: 10.1164/arrd.1966.94.1.1.

Mycoplasma and cell cultures.支原体与细胞培养

Natl Cancer Inst Monogr. 1968 Dec;29:201-4.

Protective efficacy of Mycoplasma pneumoniae polysaccharides.肺炎支原体多糖的保护效力。

Isr J Med Sci. 1981 Jul;17(7):678-81.

引用本文的文献

Infections: Pathogenesis and Vaccine Development.感染：发病机制与疫苗研发

Pathogens. 2021 Jan 25;10(2):119. doi: 10.3390/pathogens10020119.

Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.疫苗在实验性肺炎支原体病中的保护作用。

Infect Immun. 1970 Jun;1(6):559-65. doi: 10.1128/iai.1.6.559-565.1970.

Mycoplasma infections.支原体感染

Br Med J. 1966 Dec 17;2(5528):1472-3.

Mycoplasmas.支原体

Br Med J. 1965 Dec 25;2(5477):1499-500.

Infectious diseases. Annual review of significant publications.传染病。重要出版物年度综述。

Postgrad Med J. 1966 Apr;42(486):247-66. doi: 10.1136/pgmj.42.486.247.

Effect of pH on the immunogenicity of Mycoplasma pneumoniae.

J Bacteriol. 1969 Feb;97(2):612-9. doi: 10.1128/jb.97.2.612-619.1969.

[Mycoplasma (PPL organisms and their clinical importance)].[支原体（类胸膜肺炎微生物及其临床重要性）]

Beitr Klin Erforsch Tuberk Lungenkr. 1967;136(1):73-99.

Mycoplasma pneumoniae vaccine: antigenicity of buffered antigens in volunteers.肺炎支原体疫苗：志愿者中缓冲抗原的抗原性。

Infect Immun. 1972 May;5(5):657-61. doi: 10.1128/iai.5.5.657-661.1972.

Characterizion of Mycoplasma pulmonis variants isolated from rabbits. II. Basis for differentiation of antigenic subtypes.从兔分离的肺支原体变种的特性。II. 抗原亚型分化的基础。

J Bacteriol. 1967 Apr;93(4):1425-9. doi: 10.1128/jb.93.4.1425-1429.1967.

Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.用于评估肺炎支原体疫苗的仓鼠攻毒效力试验

Infect Immun. 1988 Sep;56(9):2450-7. doi: 10.1128/iai.56.9.2450-2457.1988.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验